Joint Venture: A Strategic Alliance for Growth

A Joint Venture (JV) is a business agreement in which two or more independent companies decide to combine resources to create a new business entity with a specific goal. This new entity is legally distinct from its parent companies, and the partners share the risks, costs, profits, and governance of the new venture. Forming a Joint Venture is a powerful strategic maneuver, often used to enter a new market, develop a new product or technology, or execute a large-scale project that would be too risky or expensive for a single company to undertake alone.

The main characteristic of a JV is collaboration and sharing. Each partner contributes something that the other lacks. One company may bring technology and product expertise, while the other provides capital, distribution networks, or local market knowledge. This synergy allows the Joint Venture to achieve objectives that would be unattainable for the companies individually. It is a way to accelerate growth, mitigate risks, and access new resources and competencies.

There are two main types of Joint Ventures. The corporate JV involves the creation of a new company, with a new tax ID, where each partner holds a percentage of the shares. The contractual JV does not involve creating a new company but rather a detailed contractual agreement that governs collaboration for a specific project, with clear rules about the division of responsibilities and outcomes. Regardless of the model, the success of a Joint Venture critically depends on a clear alignment of objectives, well-defined governance, and, above all, trust and transparency among the partners.

Example in the entrepreneur's routine:

Let’s imagine “BioTech Brazil,” a Brazilian startup that has developed an innovative technology for producing bioplastics from sugarcane bagasse. The technology is revolutionary, but BioTech lacks the capital and scale to build a factory and does not have access to the international market, which is its main target.

On the other hand, we have “GlobalChem,” a multinational giant in the chemical industry, with factories around the world, a vast distribution network, and significant capital. GlobalChem is under pressure from its shareholders to become more sustainable and is looking for new green technologies, but its internal R&D labs are taking too long to deliver results.

Instead of GlobalChem simply acquiring BioTech (an M&A process), the two companies decide to form a Joint Venture, “PlastiVerde S.A.” The agreement is as follows:

• BioTech Brazil joins the JV by transferring the patent and know-how of its technology. In return, it receives 40% of the shares of PlastiVerde.
• GlobalChem enters the JV with a capital investment of $50 million to build a new factory in Brazil and with its expertise in industrial production and logistics. In return, it receives 60% of the shares of PlastiVerde.

With the Joint Venture, both parties benefit. BioTech Brazil gains the production scale and access to the global market that it could never achieve alone, turning its technology into a globally impactful business. GlobalChem gains immediate access to cutting-edge technology, accelerates its sustainability strategy, and creates a new and profitable business line. PlastiVerde, the new company, is born with the agility and innovation of a startup and the strength and reach of a multinational, a powerful outcome of the strategic alliance between the two parent companies.